Time-consuming and complex: The test procedure and sample processing required for most PCR tests are labor-intensive and require specialized equipment and well-trained personnel.

Limited flexibility: PCR testing is primarily performed in a laboratory setting, meaning samples must be transported to adequate facilities and the time-to-results is delayed.

Expensive equipment: PCR equipment can be costly, which means it is less accessible, especially for communities that are already limited in resources and infrastructure.

Nucleic acid is extremely sensitive and unstable: For most PCR tests, accurate results are rely on the nucleic acid remaining intact. Transportation and handling of samples increases the risk of sample degradation, which leads to inaccurate results. 

Removing time-consuming and labor-intensive sample processing during the test procedure, lowering the chances of user error to get faster, more reliable results;

Eliminating the need for specialized equipment or trained personnel, while reducing the labor costs, making testing more accessible for all;

Relieving the pressure off of hospitals and care centers, which are already working overcapacity, by moving testing to the site of sample collection, or other locations.

CoVisAg requires no additional equipment, meaning that tests can be performed directly at the point of collection or at the patient’s side. It also reduces the time and labor costs for testing as well as the delays for getting results back, making it the most suitable test method for implementing widespread testing.

Containing the COVID-19 global pandemic will not be a simple task. Life across the world has been upturned, hindered by closed borders, empty schools, and shuttered businesses. In order for us to begin restoring life back to normal, widespread testing is the only surefire method forward.

Two of the greatest challenges to making widespread testing possible are the bottlenecks in the laboratories, which are already overwhelmed with the current rate of testing, and insufficient testing materials, resources, and infrastructure. To implement mass testing, we must be able to overcome these constraints. However, relying solely on PCR testing limits our ability to do so.

To reopen our world once again, we must be able to provide widespread testing that does not rely on time-consuming laboratory processing or expensive equipment. COVID-19 testing needs to be made easy and accessible for everyone. CoVisAg makes this possible by offering simple, fast, and portable testing at any location that delivers rapid, accurate results.